Cocrystal Pharma, Inc. (COCP) — research page
US · us-cm-kg/NASDAQ/COCP · as of 2026-11-08
Identity and listing
The issuer is Cocrystal Pharma, Inc., listed on NASDAQ under ticker COCP, with ISIN US19188J4094 and LEI 549300QCJ6RBUJKI7S66. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Segment is not on the record. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Cocrystal Pharma, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | COCP | source · 2026-11-08 |
| ISIN | US19188J4094 | source · 2026-11-08 |
| LEI | 549300QCJ6RBUJKI7S66 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 51 filings across 38 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 6 days, and the latest filing is dated 2026-11-06, 2 days before the record date. The latest filing is of type regulatory_filing. The exchange median gap is 6.0 days, the exchange median of filings is 52, and the exchange median latency is 5.0 days. The sector median gap is 6.0 days, the sector median of filings is 63.0, and the sector median latency is 4.0 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 51 | 6 | 2 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-06 | regulatory_filing | SCHEDULE 13D/A | SCHEDULE 13D/A |
| 2026-09-09 | corporate_news | 8-K | 8-K — 8-K (items 7.01,9.01) |
| 2026-08-21 | directors_dealings | 3 | 3 — 3 |
| 2026-08-18 | director_change | 8-K | 8-K — 8-K (items 5.02,9.01) |
| 2026-08-17 | corporate_news | 8-K | 8-K — 8-K (items 7.01,9.01) |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Weinberg & Company, P.A., located in Los Angeles, California. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, since EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, since the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 3 research houses: H.C. Wainwright & Co., Noble Capital Markets, Inc., and Zacks Small Cap Research.
| research house | analyst | source · read date |
|---|---|---|
| H.C. Wainwright & Co. | Raghuram Selvaraju, Ph.D. | issuer page · 2026-11-11 |
| Noble Capital Markets, Inc. | Robert LeBoyer | issuer page · 2026-11-11 |
| Zacks Small Cap Research | David Bautz, PhD | issuer page · 2026-11-11 |
Open research
The record holds no openly published research notes, as none was found.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
10 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001412486.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NASDAQ/COCP (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://www.sec.gov/Archives/edgar/data/1412486/000149315226013838/form10-k.htm (the auditor)
- 10.8
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.9
- https://ir.cocrystalpharma.com/analyst-coverage (coverage)
- 10.10
- https://mcp.us-cm-kg.ai/record/NASDAQ/COCP (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US19188J4094"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:3bea8909293eb2a2.